Journal of obstetrics and women's diseasesJournal of obstetrics and women's diseases1684-04611683-9366Eco-Vector10145610.17816/JOWD101456Conference Report, Theses of ReportInterferon therapy of herpes virus infection in pregnant womenTareevaT. G.info@eco-vector.comMalinovskayaV. V.info@eco-vector.comVitushkoS. A.info@eco-vector.comKotovY. B.info@eco-vector.comMoscow Regional Institute of Obstetrics and Gynecology15121999485S1581582202202222022022Copyright © 1999, Eсо-Vector1999<p><strong>The purpose</strong>: Determination efficiensy of interferon therapy in pregnant women with herpes infection (Cytomegalovirus, Herpes simplex virus, Epstein-Barr virus).</p>interferon therapyherpes virusViferonpregnant women<p><strong>The purpose</strong>: Determination efficiensy of interferon therapy in pregnant women with herpes infection (Cytomegalovirus, Herpes simplex virus, Epstein-Barr virus).</p>
<p><strong>Methods</strong>: The research of parameters of Inlerferon status, Immune system, hormonal homeostasis, ultrasonic scanning, virusological and bacteriological investigation are led at 154 patients, treated by x-2 interferon (viferon).</p>
<p><strong>Results</strong>: The investigation Indicated viferon has Interferon - stabilizing, immunomodulating, antioxidant effect and doesn<em>t </em>have complications on the fetus. The reducing of the delivery channel occupation with genital herpes virus in 50% of patients have been revealed. Every newborn had no signs of herpes virus infection and specifically neurological symptoms. Increased level of Interferon-gamma from initial 2.4 to 32 IU can be related to Viferon stimulation of cytokine production. Revealed immunocorrekting effect of Viferon can be a basis for its use in mothers and newborns for treatment and prophylactics of the herpes virus infection.</p>